Predict your next investment

HEALTHCARE | Medical Devices & Equipment / Therapeutic Devices
nevro.com

See what CB Insights has to offer

Founded Year

2006

Stage

IPO | IPO

Total Raised

$133.5M

Date of IPO

11/6/2014

Market Cap

2.96B

Stock Price

87.97

Revenue

$0000 

About Nevro

Nevro (NYSE: NVRO) is a global medical device company focused on providing products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain.

Nevro Headquarter Location

1800 Bridge Pkwy

Redwood City, California, 94065,

United States

650-251-0005

Latest Nevro News

Global Pain Management Devices Market Report 2021 Featuring NeuroMetrix, Medtronic, Boston Scientific, Zynex Medical, BioElectronics, SPR Therapeutics, BD & Co Abbott, & Nevro

Nov 18, 2021

Nov 18, 2021 5:00 PM EST Global Pain Management Devices Market Report 2021 Featuring NeuroMetrix, Medtronic, Boston Scientific, Zynex Medical, BioElectronics, SPR Therapeutics, BD & Co Abbott, & Nevro DUBLIN, Nov. 18, 2021 /PRNewswire/ -- The "Pain Management Devices Market - Forecasts from 2021 to 2026" report has been added to ResearchAndMarkets. Author: The global pain management devices market is expected to grow at a compound annual growth rate of 11.04% over the forecast period to reach a market size of US$10.059 billion in 2026 from US$4.834 billion in 2019. As of late there is expanded utilization of pain management devices because of ascending in maturing populace. Expansion in malignancy populace, expanding predominance of a way of life-related sickness, and expanding neuropathic messes are a portion of the key variables driving the development of the global pain management devices market. Furthermore, expanding medical services mindfulness and ascend in medical care consumption are likewise energizing the development of the worldwide pain management devices market. Be that as it may, results, for example, skin excessive touchiness, redness, and hyper-pigmentation, and accessibility of substitutes, for example, pain alleviation prescriptions are a portion of the main considerations limiting the development for worldwide pain management devices market. Lastly, taking into account the estimated increase in demand for pain management devices in the upcoming years, market players all around the globe are undertaking various strategic actions to develop new products and subsequently, increase their market share too. Growth Factors Rising prevalence of pain-inducing diseases The rising cancer cases are expected to further increase the demand for pain management devices over the forecast period. Besides, the high predominance of musculoskeletal problems, like joint inflammation, osteoarthritis, muscular degenerative issues, and rheumatoid joint pain, and a resultant ascent in instances of ongoing pain and failure to do routine errands, will support item interest. The incapability of oral medications is boosting patients to search for elective treatment choices, for example, pain management devices. The significant expenses related to hospitalization are additionally expected to help the pain management devices market as these significant expenses related to hospitalization have expanded the requirement for a diminished medical clinic stay and the need to move to more affordable consideration settings, in this way boosting item interest. Rising elderly populationThe consistently rising population of people above the age of 65 years is also expected to contribute to the pain management devices market growth. Due to increasing life expectancy and falling fertility levels, the UN explained that for the first time in history, individuals aged 65 or above outnumbered children under five years of age globally. Moreover, by 2050, one in six people in the world will be over the age of 65 (16%), up from one in 11 in 2019 (9%). Thus, with the increasing geriatric population, the demand for pain management devices is also expected to increase, considering the prevalence of arthritis in them. COVID - 19 Impact on pain management devices marketThe COVID-19 outbreak affected most of the sectors including the medical device industry. Cross country lockdowns have affected patients who explicitly depended on practice projects or PT as a pain management routine. In addition, numerous elective systems, in-person persistent visits have been suspended or postponed, which is relied upon to build the interest for at-home pain treatment, thus expected to affect the pain management devices market growth. Competitive Insights. The increasing demand for pain management devices has led to the entry of several new market players like Pain Management Technologies in the pain management devices market. The entry of these new players in a market where traditional pharma behemoths like Abbott Laboratories and Boston Scientific Corporation already exist is expected to lead to further innovation in the pain management market. Moreover, in order to further increase their clientele as well as increase their market share in the upcoming years, many of these market players have taken various strategic actions like partnerships and the development of novel solutions which primarily focus on providing comfort to the patient. For instance, in June 2020, Abbott partnered with Tandem Diabetes Care to develop integrated diabetes solutions. These strategic actions by the various competitive market players are expected to keep the market competitive and constantly evolving. Company Profiles.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Nevro

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Nevro is included in 2 Expert Collections, including Diabetes.

D

Diabetes

1,750 items

M

Medical Devices

949 items

https://www.advamed.org/membership-join/membership-directory/ - excludes those without working websites.

Nevro Patents

Nevro has filed 197 patents.

The 3 most popular patent topics include:

  • Neurotechnology
  • Neurophysiology
  • Neurological disorders
patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/30/2019

10/19/2021

Wireless networking, Implants (medicine), Radio frequency antenna types, Electronic test equipment, Microwave technology

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

4/30/2019

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

10/19/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Wireless networking, Implants (medicine), Radio frequency antenna types, Electronic test equipment, Microwave technology

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Nevro Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Nevro Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.